Full Text
The Full Text of this article is available as a PDF (80.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bingle L., Tetley T. D. Secretory leukoprotease inhibitor: partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation. Thorax. 1996 Dec;51(12):1273–1274. doi: 10.1136/thx.51.12.1273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dijkman J. H., Kramps J. A., Franken C. Antileukoprotease in sputum during bronchial infections. Chest. 1986 May;89(5):731–736. doi: 10.1378/chest.89.5.731. [DOI] [PubMed] [Google Scholar]
- Hiemstra P. S., Maassen R. J., Stolk J., Heinzel-Wieland R., Steffens G. J., Dijkman J. H. Antibacterial activity of antileukoprotease. Infect Immun. 1996 Nov;64(11):4520–4524. doi: 10.1128/iai.64.11.4520-4524.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luzzatto L., Bessler M., Rotoli B. Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell. 1997 Jan 10;88(1):1–4. doi: 10.1016/s0092-8674(00)81850-4. [DOI] [PubMed] [Google Scholar]
- McElvaney N. G., Doujaiji B., Moan M. J., Burnham M. R., Wu M. C., Crystal R. G. Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis. Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):1056–1060. doi: 10.1164/ajrccm/148.4_Pt_1.1056. [DOI] [PubMed] [Google Scholar]
- McElvaney N. G., Nakamura H., Birrer P., Hébert C. A., Wong W. L., Alphonso M., Baker J. B., Catalano M. A., Crystal R. G. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest. 1992 Oct;90(4):1296–1301. doi: 10.1172/JCI115994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McNeely T. B., Dealy M., Dripps D. J., Orenstein J. M., Eisenberg S. P., Wahl S. M. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest. 1995 Jul;96(1):456–464. doi: 10.1172/JCI118056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller K. W., Evans R. J., Eisenberg S. P., Thompson R. C. Secretory leukocyte protease inhibitor binding to mRNA and DNA as a possible cause of toxicity to Escherichia coli. J Bacteriol. 1989 Apr;171(4):2166–2172. doi: 10.1128/jb.171.4.2166-2172.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rudolphus A., Stolk J., Dijkman J. H., Kramps J. A. Inhibition of lipopolysaccharide-induced pulmonary emphysema by intratracheally instilled recombinant secretory leukocyte proteinase inhibitor. Am Rev Respir Dis. 1993 Feb;147(2):442–447. doi: 10.1164/ajrccm/147.2.442. [DOI] [PubMed] [Google Scholar]
- Sponer M., Nick H. P., Schnebli H. P. Different susceptibility of elastase inhibitors to inactivation by proteinases from Staphylococcus aureus and Pseudomonas aeruginosa. Biol Chem Hoppe Seyler. 1991 Nov;372(11):963–970. doi: 10.1515/bchm3.1991.372.2.963. [DOI] [PubMed] [Google Scholar]
- Tomee J. F., Hiemstra P. S., Heinzel-Wieland R., Kauffman H. F. Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J Infect Dis. 1997 Sep;176(3):740–747. doi: 10.1086/514098. [DOI] [PubMed] [Google Scholar]
- Tomee J. F., Wierenga A. T., Hiemstra P. S., Kauffman H. K. Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis. 1997 Jul;176(1):300–303. doi: 10.1086/517272. [DOI] [PubMed] [Google Scholar]
- Turpin J. A., Schaeffer C. A., Bu M., Graham L., Buckheit R. W., Jr, Clanton D., Rice W. G. Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor. Antiviral Res. 1996 Mar;29(2-3):269–277. doi: 10.1016/0166-3542(95)00907-8. [DOI] [PubMed] [Google Scholar]